These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 34533265)

  • 21. Pityriasis rosea Gibert triggered by SARS-CoV-2 infection: A case report.
    Birlutiu V; Birlutiu RM; Iancu GM
    Medicine (Baltimore); 2021 Apr; 100(14):e25352. PubMed ID: 33832113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SARS-CoV-2 vaccine-related cutaneous manifestations: a systematic review.
    Avallone G; Quaglino P; Cavallo F; Roccuzzo G; Ribero S; Zalaudek I; Conforti C
    Int J Dermatol; 2022 Oct; 61(10):1187-1204. PubMed ID: 35141881
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Persistent pityriasis rosea: an unusual form of pityriasis rosea with persistent active HHV-6 and HHV-7 infection.
    Drago F; Broccolo F; Ciccarese G; Rebora A; Parodi A
    Dermatology; 2015; 230(1):23-6. PubMed ID: 25612842
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pityriasis rosea-like drug eruption due to bupropion: a case report.
    Polat M; Uzun Ö; Örs I; Boran Ç
    Hum Exp Toxicol; 2014 Dec; 33(12):1294-6. PubMed ID: 24700110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccine-induced pityriasis rosea and pityriasis rosea-like eruptions: a review of the literature.
    Drago F; Ciccarese G; Javor S; Parodi A
    J Eur Acad Dermatol Venereol; 2016 Mar; 30(3):544-5. PubMed ID: 25545307
    [No Abstract]   [Full Text] [Related]  

  • 26. The clinics of HHV-6 infection in COVID-19 pandemic: Pityriasis rosea and Kawasaki disease.
    Dursun R; Temiz SA
    Dermatol Ther; 2020 Jul; 33(4):e13730. PubMed ID: 32475003
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of high-dose acyclovir in pityriasis rosea.
    Drago F; Vecchio F; Rebora A
    J Am Acad Dermatol; 2006 Jan; 54(1):82-5. PubMed ID: 16384760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pityriasis Rosea Following Pfizer-BioNTech Vaccination in an Adolescent Girl.
    Bin Rubaian NF; Almuhaidib SR; Aljarri SA; Alamri AS
    Cureus; 2022 Jul; 14(7):e27108. PubMed ID: 36004038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pityriasis Rosea: A Comprehensive Classification.
    Drago F; Ciccarese G; Rebora A; Broccolo F; Parodi A
    Dermatology; 2016; 232(4):431-7. PubMed ID: 27096928
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of human herpes virus 6 and 7 in the pathogenesis of pityriasis rosea.
    Yildirim M; Aridogan BC; Baysal V; Inaloz HS
    Int J Clin Pract; 2004 Feb; 58(2):119-21. PubMed ID: 15055857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relapsing Pityriasis Rosea With HHV-7 Reactivation in an 11-Year-Old Girl.
    Engelmann I; Ogiez J; Ogiez L; Alidjinou EK; Lazrek M; Dewilde A; Hober D
    Pediatrics; 2018 May; 141(5):. PubMed ID: 29674359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pityriasis rosea-like eruption associated with ondansetron use in pregnancy.
    Alame MM; Chamsy DJ; Zaraket H
    Br J Clin Pharmacol; 2018 May; 84(5):1077-1080. PubMed ID: 29520857
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pityriasis Rosea Induced by COVID-19 Vaccination.
    Khattab E; Christaki E; Pitsios C
    Eur J Case Rep Intern Med; 2022; 9(2):003164. PubMed ID: 35265550
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pityriasis rosea-like eruptions following vaccination with BNT162b2 mRNA COVID-19 Vaccine.
    Cyrenne BM; Al-Mohammedi F; DeKoven JG; Alhusayen R
    J Eur Acad Dermatol Venereol; 2021 Sep; 35(9):e546-e548. PubMed ID: 33982814
    [No Abstract]   [Full Text] [Related]  

  • 35. Pityriasis rosea-like eruption after Pfizer-BioNTech COVID-19 vaccination.
    Carballido Vázquez AM; Morgado B
    Br J Dermatol; 2021 Aug; 185(2):e34. PubMed ID: 33904157
    [No Abstract]   [Full Text] [Related]  

  • 36. Pityriasis rosea-like drug eruption due to nortriptyline in a patient with vulvodynia.
    Bangash HK; Finch T; Petronic-Rosic V; Sethi A; Abramsohn E; Lindau ST
    J Low Genit Tract Dis; 2013 Apr; 17(2):226-9. PubMed ID: 23343697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Palmar herald patch in pityriasis rosea.
    Polat M; Yildirim Y; Makara A
    Australas J Dermatol; 2012 Aug; 53(3):e64-5. PubMed ID: 22881477
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pityriasis rosea in a hepatitis B-positive patient treated with pegylated interferon α2a: report of a case and review of the literature.
    Drago F; Javor S; Bruzzone L; Drago F; Parodi A; Picciotto A
    Dermatology; 2014; 228(1):10-3. PubMed ID: 24335203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pityriasis Rosea: Diagnosis and Treatment.
    Villalon-Gomez JM
    Am Fam Physician; 2018 Jan; 97(1):38-44. PubMed ID: 29365241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atypical presentations of pityriasis rosea: case presentations.
    Chuh A; Zawar V; Lee A
    J Eur Acad Dermatol Venereol; 2005 Jan; 19(1):120-6. PubMed ID: 15649208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.